Skip to main content
Kevin David, MD, Oncology, New Brunswick, NJ, Robert Wood Johnson University Hospital

KevinAndrewDavidMD

Oncology New Brunswick, NJ

Hematologic Oncology

Assistant Professor, Medicine, UMDNJ-Robert Wood Johnson Medical School

Dr. David is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. David's full profile

Already have an account?

  • Office

    195 Little Albany Street - East Tower 9th Floor
    Room 990
    New Brunswick, NJ 08901
    Phone(732) 235-4599
    Fax(732) 448-7894
  • Is this information wrong?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology/Oncology, 2006 - 2009
  • Washington University - Barnes-Jewish Hospital
    Washington University - Barnes-Jewish HospitalResidency, Internal Medicine, 2002 - 2005
  • Columbia University School of Public HealthClass of 2002

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2009 - 2023
  • IL State Medical License
    IL State Medical License 2006 - 2011
  • NY State Medical License
    NY State Medical License 2005 - 2007
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma
    Kevin A. David, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase I/II Study of Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: PrE0408
    Kevin A. David, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
    Kevin A. David, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Retrospective Analysis Identifies Need for Better Classification of Rare Lymphoma
    Retrospective Analysis Identifies Need for Better Classification of Rare LymphomaDecember 4th, 2019
  • Combination Immunotherapy Shows High Activity Against Recurrent Hodgkin Lymphoma
    Combination Immunotherapy Shows High Activity Against Recurrent Hodgkin LymphomaDecember 3rd, 2018
  • Blood Cancer Cures and Care: Addressing Leukemia and Lymphoma
    Blood Cancer Cures and Care: Addressing Leukemia and LymphomaSeptember 10th, 2021
  • Join now to see all

Hospital Affiliations